$22 Million Joint Venture To Purse Neurochemical Reset For Addiction

Posted by:

[ad_1]

The $22 million investment from ATAI will develop the drug ibogaine which is derived from the iboga plant that has previously been sold as a stimulant …

[ad_2]

Source link

0
UA-77446339-1